|DEFLAZACORT||6 MG||30 MG|
|PACKING TYPE||ALU ALU||ALU ALU||–|
|MRP||850 / 900||4800||68|
Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant. It was approved in February, 2017 by the FDA for use in treatment of Duchenne muscular dystrophy (trade name Emflaza).
The LD50 for the oral dose is greater than 4000 mg/kg in laboratory animals.
corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.